Tuesday, February 6th, 2018 - Market Research Future

Eisai, Co. Ltd. (Japan), Pfizer (US), Merck & Co Inc (US), Sanofi (France), Takeda Pharmaceutical Company (Japan),  Meda Consumer Healthcare Inc (US), Pernix Therapeutics (US), Purdue Pharma L.P. (US), Johnson & Johnson (US),  Astellas (UK), Biocodex S A (France), and Vanda Pharmaceuticals Inc. (US) are some of the prominent players at the forefront of competition in the Insomnia Market and are profiled in MRFR Analysis.

Global Insomnia Market - Overview

The global insomnia market is growing mainly due to the stressful work conditions. According to a recent study report published by the Market Research Future, The global insomnia market is booming and expected to gain prominence over the forecast period. The market is forecasted to demonstrate a spectacular growth by 2023, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2023).

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/545 .

Insomnia is a common sleep disorder characterized by difficulties in sleep. Insomnia can exist as it’s alone or conjugated with other psychiatric problems. Insomnia is most common is women and the severity may increase in conditions like pregnancy, postpartum, and menopause. The exact cause of insomnia is still a mystery. Many research has shown that biological, behavioural and psychological factors are responsible for initiating of insomnia.

Different types of treatment are available in the market- Pharmacological and non-pharmacological treatment. According to a study published in 2017, it is found that prevalence of insomnia in China was around 15.0% which is lower than the other countries such as 27.1% in USA, 37.2% in France and Italy, 50.5% in Poland, 17.3% in Singapore, and 15.3% in Japan.

Global Insomnia Market - Competitive Analysis

The global insomnia treatment market is currently dominated by few players.

Merck & Co., Inc. is one of them by holding a strong share in the market. The company’s stronghold is largely attributed to its innovative and sustainable products. On August 14, 2014 Merck received FDA approval for its insomnia drug i.e. Belsomra (suvorexant). The FDA has approved this drug in four different strengths i.e. 5 mg, 10 mg, 15 mg and 20 mg.

Meda Consumer Healthcare Inc. is also one of the leading player in insomnia market. The company has three medicine known as MidNite Sleep aid, MidNite PM for Pain and MidNite for Menopause. The company has significantly expanded its leadership in sleep and alertness aid segment and Vivarin alertness aid. The company has also acquired the MidNite brand.

Vanda Pharmaceuticals Inc., a US based biopharmaceutical company, focuses on the development of commercialization of innovative therapy and is constantly working for the unmet need and for the improvement of the patients’ lives.  In January, 2014, the company has received approval for insomnia product i.e. Helitoz trasimelteon.

Order Copy of 85 Premium Pages is Available @ https://www.marketresearchfuture.com/order_form.pdf?report_id=545 .

The medicine is used to treat 24- hours sleep wake disorder. Also the other product Hetlioz got approval from European Commission in July 2015 to launch the product in European market.

Eisai, Co. is an old company which into making medicine for the insomnia. Company is a larger player in the Japanese market. Company has acquired the manufacturing rights to make API and as well the IPR right from Chugai and Roche to treat insomnia. The marketing authorization are transferred as well as the transition of marketing activities for Rohypnol from Chugai to Eisai and are applicable from April 1, 2017.

Brief TOC

  1. Introduction    
  2. Research Methodology    
  3. Market Dynamics    
  4. Market Factor Analysis    
  5. Global Insomnia Market, By Types Of Therapy 
  6. Global Insomnia Market, By Drug Formulation 
  7. Global Insomnia Market, By Diseases Condition
  8. Global Insomnia Market, By Region
  9. Competitive Landscape    
  10. Company Profile    

Ask to Expert @ https://www.marketresearchfuture.com/enquiry/545 .

Key questions answered in this report

What will the market size be in 2023 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Contact Profile

Market Research Future


At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.


Akash Anand
P: +1 646 845 9312
W: www.marketresearchfuture.com

Keywords

Insomnia Market, Global Insomnia Market, Insomnia Industry, Insomnia Market Size, Insomnia Market Share, Insomnia Market Research, Insomnia Market Trends, Insomnia

Categories

Newsrooms

Sharing

More Formats

View QR Code